drugset / Trial / NCT03445884

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis

NCT03445884 ↗

Phase 2 Completed 42 enrolled Rigshospitalet, Denmark
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The aim is to examine the expression of αvβ3 integrin using a novel selective radiotracer in patients with myocardial infarction and investigate if it is a suitable tool for predicting myocardial recovery and thus prognosis.

Timeline

Start
2018-02-20
Primary completion
2020-07-01
Completion
2020-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NODAGA-E[c(RGDyK)]2 Diagnostic / imaging agent 200 mbq Intravenous